Northern Trust
ORKA

Northern Trust’s Oruka Therapeutics ORKA Stock Holding History

Northern Trust’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$14.7M Buy
299,044
+18,140
+6% +$630K ﹤0.01% 1859
2025
Q4 		$8.51M Buy
280,904
+61,195
+28% +$1.71M ﹤0.01% 2168
2025
Q3 		$4.23M Sell
219,709
-2,469
-1% -$36.6K ﹤0.01% 2602
2025
Q2 		$2.49M Buy
222,178
+162,593
+273% +$1.69M ﹤0.01% 2859
2025
Q1 		$611K Sell
59,585
-4,459
-7% -$55.6K ﹤0.01% 3493
2024
Q4 		$1.24M Buy
+64,044
New +$1.56M ﹤0.01% 3293
2024
Q3 		– Sell
-1,749
Closed -$80.4K – 4459
2024
Q2 		$80.4K Hold
1,749
– – ﹤0.01% 4096
2024
Q1 		$36.9K Hold
1,749
– – ﹤0.01% 4268
2023
Q4 		$35.7K Hold
1,749
– – ﹤0.01% 4293
2023
Q3 		$42.2K Hold
1,749
– – ﹤0.01% 4206
2023
Q2 		$42.6K Hold
1,749
– – ﹤0.01% 4254
2023
Q1 		$41.8K Buy
1,749
+289
+20% +$7.62K ﹤0.01% 4295
2022
Q4 		$41.5K Hold
1,460
– – ﹤0.01% 4325
2022
Q3 		$36K Hold
1,460
– – ﹤0.01% 4415
2022
Q2 		$44K Hold
1,460
– – ﹤0.01% 4443
2022
Q1 		$40K Hold
1,460
– – ﹤0.01% 4581
2021
Q4 		$38K Hold
1,460
– – ﹤0.01% 4635
2021
Q3 		$52K Hold
1,460
– – ﹤0.01% 4531
2021
Q2 		$61K Hold
1,460
– – ﹤0.01% 4457
2021
Q1 		$64K Hold
1,460
– – ﹤0.01% 4355
2020
Q4 		$70K Buy
+1,460
New +$72.7K ﹤0.01% 4185
2019
Q2 		– Sell
-65
Closed -$5K – 4300
2019
Q1 		$5K Hold
65
– – ﹤0.01% 4199
2018
Q4 		$5K Hold
65
– – ﹤0.01% 4238
2018
Q3 		$8K Hold
65
– – ﹤0.01% 4265
2018
Q2 		$8K Hold
65
– – ﹤0.01% 4264
2018
Q1 		$7K Hold
65
– – ﹤0.01% 4216
2017
Q4 		$19K Buy
65
+14
+27% +$4.05K ﹤0.01% 4160
2017
Q3 		$13K Hold
51
– – ﹤0.01% 4186
2017
Q2 		$26K Hold
51
– – ﹤0.01% 4160
2017
Q1 		$28K Buy
+51
New +$28.5K ﹤0.01% 4124
2014
Q1 		– Sell
-21
Closed -$53K – 4211
2013
Q4 		$53K Buy
+21
New +$48.5K ﹤0.01% 3969

Other funds holding ORKA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Northern Trust's ORKA Position: Q1 2026 in Review

Northern Trust increased its Oruka Therapeutics (ORKA) stake by 6.5% in Q1 2026, buying an estimated $630K and bringing the position to 299,044 shares worth $14.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1859.

Northern Trust first reported a position in ORKA in Q4 2013 and has held it in 31 quarters since. 184 funds tracked by Wall St. Rank hold ORKA as of Q1 2026.

  • Northern Trust held 299,044 shares of Oruka Therapeutics worth $14.7M as of Q1 2026.
  • Northern Trust bought 18,140 Oruka Therapeutics shares in Q1 2026, an estimated $630K.
  • Oruka Therapeutics made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #1859 holding.
  • Northern Trust first reported a position in Oruka Therapeutics in Q4 2013 and has held it in 31 quarters since.
  • 184 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.